SAR studies in a series of 3-heteroarylthio substituted cephalosporins esta
blished that high activity against methicillin-resistant Staphylococcus aur
eus (MRSA) can be achieved with various heteroaryl substituents. Early resu
lts showed that highly lipophilic 3-heteroarylthio substituents, which were
necessary for anti-MRSA activity, caused high affinity of such cephems tow
ard serum proteins. Our earlier published efforts described discovery of zw
itterionic cephems MC-02,331 and RWJ-54428 (MC-02,479), where serum binding
was reduced by employing basic, positively charged functionalities attache
d to the 3-heteroarylthio substituent. In order to avoid low solubility pro
blems associated with most such zwitterionic cephalosporins a wide variety
of non-basic heteroaryl substituents was tested (non-zwitterionic cephems a
re more easily formulated as water soluble sodium salts for intravenous adm
inistration). Considerable reduction in serum binding was obtained in some
analogs while maintaining high anti-MRSA potency.